Correction to “Targeting the Spike: Repurposing Mithramycin and Dihydroergotamine to Block SARS-CoV‑2 Infection”
Soledad Stagnoli,
Gabriele Macari,
Pietro Corsi,
Barbara Capone,
Ander Vidaurrazaga,
June Ereño-Orbea,
Ana Ardá,
Fabio Polticelli,
Jesus Jimenez-Barbero,
Nicola GA Abrescia,
Ivan Coluzza
Affiliations
Soledad Stagnoli
Structure and Cell Biology of Viruses Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain
Gabriele Macari
Department of Sciences, University of Rome Tre, Rome, Italy
Pietro Corsi
Department of Sciences, University of Rome Tre, Rome, Italy
Barbara Capone
Department of Sciences, University of Rome Tre, Rome, Italy
Ander Vidaurrazaga
Structure and Cell Biology of Viruses Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain
June Ereño-Orbea
Chemical Glycobiology Laboratory, CIC bioGUNE, BRTA, Derio, Spain
Ana Ardá
Chemical Glycobiology Laboratory, CIC bioGUNE, BRTA, Derio, Spain
Fabio Polticelli
Department of Sciences, University of Rome Tre, Rome, Italy
Jesus Jimenez-Barbero
Chemical Glycobiology Laboratory, CIC bioGUNE, BRTA, Derio, Spain
Nicola GA Abrescia
Structure and Cell Biology of Viruses Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain
Ivan Coluzza
IKERBASQUE, Basque Foundation for Science, Bilbao, Spain
